Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof
Details for Australian Patent Application No. 2006291060 (hide)
International Classifications
Event Publications
17 April 2008 PCT application entered the National Phase
PCT publication WO2007/033193 Priority application(s): WO2007/033193
12 June 2008 Assignment before Grant
Wyeth The application has been assigned to Solvay Pharmaceuticals B.V.
29 September 2011 Application Accepted
Published as AU-B-2006291060
2 February 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006291062-Gaming floor control and configuration system
2006291059-Salicylate and gentisate salts of a piperazine compound
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser